ARAY Accuray: Company Short-Term Debts

Symbol and logo of brand Accuray Incorporated (ARAY)

Accuray Incorporated (ARAY) maintains an impeccable reputation as the creator of CyberKnife systems, enjoying global recognition within the medical community. The business relies on providing cutting-edge oncology therapy services and patient support. Management is implementing high-precision developments to accelerate clinical procedures. This price chart on GURU.Markets reflects the asset's dynamics, where the current figure stands at 0.01, confirming the company's status in the sector.

ARAY Accuray Inc Company Short-Term Loans and Borrowings (07/04/2022 - 10/29/2026)

ARAY (Accuray, Inc.): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price Accuray|ARAY - Consensus Target
- company stock capitalization data:
Market Capitalization Accuray|ARAY - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Accuray Incorporated|ARAY - Accounting Value of Company|Market Cap to Net Assets Ratio accuray.com|ARAY - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital Accuray Incorporated|ARAY - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Accuray Incorporated|ARAY - Company Aggregate Debts|Debt to Book Capitalization Ratio Accuray|ARAY - Company Long-Term Loans and Borrowings|Company Short-Term Debts Accuray Incorporated|Quick Ratio accuray.com
- earnings and multiples data:
ARAY - Net Profit
Analysis of all company metrics:ARAY - Accuray
Manufactured products of accuray.com

The complex logistics of Accuray Incorporated (ARAY) radiation therapy systems require significant working capital to maintain supply chains. This metric aggregates all credit obligations with maturities of up to one year. Rising debt amid stable cash flow confirms growth, yet excessive debt threatens a liquidity gap. It is critical for investors to benchmark these amounts against operating revenue. Constant monitoring of short-term liabilities allows for a timely assessment of default risk.

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|candeltx.com (CADL) - Company Short-Term Debt|SELLAS Life Sciences Group - Company Short-Term Loans and Borrowings|ACTU (Actuate Therapeutics, Inc) - Company Short-Term Debts|Short-Term Debt Citius Oncology Inc CTOR|Company Short-Term Debts HURA|Company Short-Term Debts protaratx.com (TARA)|Company Short-Term Debts FATE (Fate Therapeutics)|WHWK - Company Current Liabilities|TScan - Company Short-Term Debts|Champions Oncology (CSBR) - Company Current Liabilities|XBIT (xbiotech.com) - Company Current Liabilities|CEL-SCI (CVM) - Company Short-Term Debts|Company Short-Term Debt OS Therapies|RADX: Company Short-Term Loans and Borrowings|Company Short-Term Debts ARTV|Company Short-Term Debts adlainortye.com (ANL)|Veru Inc. - Company Current Liabilities|tempesttx.com (TPST) - Short-Term Debt|XLO: Company Current Liabilities|Company Short-Term Loans and Borrowings RENB (Renovaro Inc.)|MURA: Company Short-Term Debts|KAPA - Short-Term Debt Volume|Company Short-Term Debt OnKure Therapeutics, Inc.|Company Short-Term Indebtedness GDTC (CytoMed)|Company Short-Term Debts CRIS|Company Current Liabilities apollomicsinc.com APLM|Company Short-Term Debt Tharimmune Corp THAR|Advanced Biomed Inc. (ADVB) - Short-Term Debt|GNPX - Company Short-Term Debt|Company Short-Term Loans and Borrowings CLDI (Calidi Biotherapeutics)|Sunshine Biopharma (SBFM) - Company Short-Term Debt|Current Liabilities XBIO (Xenetic Biosciences, Inc.)|Company Short-Term Debt Salarius|Short-Term Debt Kitov Pharma PPBT|Company Short-Term Debt American Oncology Network (AONC)|BGNE (beigene.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts CKPT (Checkpoint Therapeutics, Inc.)|Company Short-Term Debts Elevation Oncology Inc. ELEV|ICAD: Company Current Liabilities|Ikena Oncology, Inc. - Amount of Current Liabilities|NTBL: Company Short-Term Debts|Short-Term Debt Viracta Therapeutics, Inc. (VIRX)|MOR (MorphoSys) - Company Short-Term Debts|Company Short-Term Indebtedness NAYA (NAYA Biosciences Inc)|Company Short-Term Debts AAPGV